Lynch Associatesin Lowers stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Lynch Associatesin reduced its stake in Stryker Corporation by 1.18% during the most recent quarter end. The investment management company now holds a total of 27,250 shares of Stryker Corporation which is valued at $3,178,985 after selling 325 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Oct 4, 2016.Stryker Corporation makes up approximately 1.41% of Lynch Associatesin’s portfolio.

Other Hedge Funds, Including , Lau Associates sold out all of its stake in SYK during the most recent quarter. The investment firm sold 1,700 shares of SYK which is valued $198,322.Bath Savings Trust Co boosted its stake in SYK in the latest quarter, The investment management firm added 547 additional shares and now holds a total of 66,267 shares of Stryker Corporation which is valued at $7,730,708. Stryker Corporation makes up approx 2.44% of Bath Savings Trust Co’s portfolio.Cullinan Associates Inc reduced its stake in SYK by selling 3,225 shares or 62.93% in the most recent quarter. The Hedge Fund company now holds 1,900 shares of SYK which is valued at $221,654. Stryker Corporation makes up approx 0.02% of Cullinan Associates Inc’s portfolio. Beacon Financial Group sold out all of its stake in SYK during the most recent quarter. The investment firm sold 2,981 shares of SYK which is valued $347,763.

Stryker Corporation closed down -0.19 points or -0.16% at $116.26 with 10,74,069 shares getting traded on Tuesday. Post opening the session at $116.48, the shares hit an intraday low of $115.73 and an intraday high of $116.92 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.